Webinars Related to HEAL Preclinical Analgesic Development Funding announcements
Tue, 1/19/2021
Details
Tuesday, January 19, 2021
View the presentations
- RFA-NS-21-010: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) pdf 3.06 MB
- RFA-NS-21-015/RFA-NS-21-016: Non-addictive Analgesic Therapeutics Development pdf 1.35 MB
View the webinar recordings
HEAL Initiative_Non-addictive Analgesic Therapeutics Development Small Molecules and Biologics to Treat Pain (UG3_UH3 Clinical Trial Optional) FOA Webinar Presentation.
Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
HEAL Initiative_Planning Studies (RFA-NS-21-016) and Team Research (RFA-NS-21-015) for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development FOAs are discussed in a webinar presentation.